Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M El-Hashimy

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Diabetes|March 1, 1995
Factors modifying the risk of IDDM in offspring of an IDDM parentM el-Hashimy, M C Angelico, B C Martin, et al.
Diabetes|June 1, 1997
Acute postchallenge hyperinsulinemia predicts weight gain: a prospective studyR J Sigal, M El-Hashimy, B C Martin, et al.
American Journal of Public Health|March 1, 1997
Strategies to improve the reporting of legal blindness in MassachusettsM M el-Hashimy, R E Aubert, K Alich, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 12, 2014
Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2H S Rugo, K I Pritchard, M Gnant, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Diabetes|March 1, 1995
Factors modifying the risk of IDDM in offspring of an IDDM parentM el-Hashimy, M C Angelico, B C Martin, et al.
Diabetes|June 1, 1997
Acute postchallenge hyperinsulinemia predicts weight gain: a prospective studyR J Sigal, M El-Hashimy, B C Martin, et al.
American Journal of Public Health|March 1, 1997
Strategies to improve the reporting of legal blindness in MassachusettsM M el-Hashimy, R E Aubert, K Alich, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 12, 2014
Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2H S Rugo, K I Pritchard, M Gnant, et al.
Pageof 1